[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609824":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":34,"centralContacts":43,"locations":49,"responsibleParty":242,"collaborators":34,"id":244,"slug":34,"hasResults":245,"nctId":246,"briefTitle":247,"officialTitle":248,"acronym":249,"eligibilityCriteria":250,"healthyVolunteers":245,"sex":251,"minAge":252,"maxAge":34,"enrollmentInfo":253,"targetDuration":34,"studyType":256,"phases":257,"briefSummary":259,"conditions":260,"keywords":34,"overallStatus":52,"whyStopped":34,"lastUpdateSubmitDate":264,"lastUpdatePostDateStruct":265,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":273},{"fullName":5,"class":6},"NewAmsterdam Pharma","INDUSTRY",[8,14,19,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Obicetrapib\u002FEzetimibe","EXPERIMENTAL","obicetrapib 10 mg + ezetimibe 10 mg FDC daily",[13],"Drug: obicetrapib 10 mg + ezetimibe 10 mg FDC daily",{"label":15,"type":10,"description":16,"interventionNames":17},"Obicetrapib","obicetrapib 10 mg daily",[18],"Drug: Obicetrapib 10 mg",{"label":20,"type":21,"description":22,"interventionNames":23},"Placebo","PLACEBO_COMPARATOR","Placebo on top of guideline-recommended lipid-lowering therapy",[24],"Other: Placebo",{"label":26,"type":10,"description":27,"interventionNames":28},"Open-Label Extension","Open-Label Extension (OLE) with the FDC of Obicetrapib 10 mg and Ezetimibe 10 mg",[13],[30,35,39],{"type":31,"name":11,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","FDC",[9,26],null,{"type":31,"name":36,"description":37,"armGroupLabels":38,"otherNames":34},"Obicetrapib 10 mg","monotherapy",[15],{"type":40,"name":20,"description":41,"armGroupLabels":42,"otherNames":34},"OTHER","placebo on top of guideline-recommended lipid modifying therapy",[20],[44],{"name":45,"role":46,"phone":47,"phoneExt":34,"email":48},"Gagandeep Dhillon","CONTACT","519-209-2341","Gagandeep.dhillon@fortrea.com",[50,64,74,84,90,98,107,117,127,137,147,157,167,177,185,194,204,214,223,233],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":34},"Clinical Research Institute of Arizona","RECRUITING","Sun City West","Arizona","85375","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-112.34127,33.66198,{"lat":62,"lon":61},{"facility":65,"status":52,"city":66,"state":67,"zip":68,"country":56,"countryCode":57,"cosmosGeoPoint":69,"geoPoint":73,"contacts":34},"Scripps Health - Whittier Diabetes Institute","La Jolla","California","92037",{"type":59,"coordinates":70},[71,72],-117.2742,32.84727,{"lat":72,"lon":71},{"facility":75,"status":52,"city":76,"state":77,"zip":78,"country":56,"countryCode":57,"cosmosGeoPoint":79,"geoPoint":83,"contacts":34},"UF Health Jackson","Jacksonville","Florida","32209",{"type":59,"coordinates":80},[81,82],-81.65565,30.33218,{"lat":82,"lon":81},{"facility":85,"status":52,"city":76,"state":77,"zip":86,"country":56,"countryCode":57,"cosmosGeoPoint":87,"geoPoint":89,"contacts":34},"East Coast Institute of Research LLC","32216",{"type":59,"coordinates":88},[81,82],{"lat":82,"lon":81},{"facility":85,"status":52,"city":91,"state":77,"zip":92,"country":56,"countryCode":57,"cosmosGeoPoint":93,"geoPoint":97,"contacts":34},"Lake City","32055",{"type":59,"coordinates":94},[95,96],-82.63929,30.18968,{"lat":96,"lon":95},{"facility":99,"status":52,"city":100,"state":77,"zip":101,"country":56,"countryCode":57,"cosmosGeoPoint":102,"geoPoint":106,"contacts":34},"Floridian Clinical Research","Miami Lakes","33016",{"type":59,"coordinates":103},[104,105],-80.30866,25.90871,{"lat":105,"lon":104},{"facility":108,"status":52,"city":109,"state":110,"zip":111,"country":56,"countryCode":57,"cosmosGeoPoint":112,"geoPoint":116,"contacts":34},"Louisville Metabolic and Atherosclerosis Research Center (L-MARC)","Louisville","Kentucky","40213",{"type":59,"coordinates":113},[114,115],-85.75941,38.25424,{"lat":115,"lon":114},{"facility":118,"status":52,"city":119,"state":120,"zip":121,"country":56,"countryCode":57,"cosmosGeoPoint":122,"geoPoint":126,"contacts":34},"MD Medical Research","Oxon Hill","Maryland","20745",{"type":59,"coordinates":123},[124,125],-76.9897,38.80345,{"lat":125,"lon":124},{"facility":128,"status":52,"city":129,"state":130,"zip":131,"country":56,"countryCode":57,"cosmosGeoPoint":132,"geoPoint":136,"contacts":34},"Jefferson City Medical Group","Jefferson City","Missouri","65109",{"type":59,"coordinates":133},[134,135],-92.17352,38.5767,{"lat":135,"lon":134},{"facility":138,"status":52,"city":139,"state":140,"zip":141,"country":56,"countryCode":57,"cosmosGeoPoint":142,"geoPoint":146,"contacts":34},"Montana Medical Research","Missoula","Montana","59808",{"type":59,"coordinates":143},[144,145],-113.994,46.87215,{"lat":145,"lon":144},{"facility":148,"status":52,"city":149,"state":150,"zip":151,"country":56,"countryCode":57,"cosmosGeoPoint":152,"geoPoint":156,"contacts":34},"Inspira Health - Internal Medicine Associates","Bridgeton","New Jersey","08302",{"type":59,"coordinates":153},[154,155],-75.23408,39.42734,{"lat":155,"lon":154},{"facility":158,"status":52,"city":159,"state":160,"zip":161,"country":56,"countryCode":57,"cosmosGeoPoint":162,"geoPoint":166,"contacts":34},"Central New York Clinical Research","Manlius","New York","13104",{"type":59,"coordinates":163},[164,165],-75.97686,43.00201,{"lat":165,"lon":164},{"facility":168,"status":52,"city":169,"state":170,"zip":171,"country":56,"countryCode":57,"cosmosGeoPoint":172,"geoPoint":176,"contacts":34},"Velocity Clinical Research","Durham","North Carolina","27710",{"type":59,"coordinates":173},[174,175],-78.89862,35.99403,{"lat":175,"lon":174},{"facility":99,"status":52,"city":178,"state":170,"zip":179,"country":56,"countryCode":57,"cosmosGeoPoint":180,"geoPoint":184,"contacts":34},"Greensboro","27408",{"type":59,"coordinates":181},[182,183],-79.79198,36.07264,{"lat":183,"lon":182},{"facility":186,"status":52,"city":187,"state":170,"zip":188,"country":56,"countryCode":57,"cosmosGeoPoint":189,"geoPoint":193,"contacts":34},"Centricity Research dba Lucas Research","Morehead City","28557",{"type":59,"coordinates":190},[191,192],-76.72604,34.72294,{"lat":192,"lon":191},{"facility":195,"status":52,"city":196,"state":197,"zip":198,"country":56,"countryCode":57,"cosmosGeoPoint":199,"geoPoint":203,"contacts":34},"Summit Research Group","Munroe Falls","Ohio","44262",{"type":59,"coordinates":200},[201,202],-81.43983,41.1445,{"lat":202,"lon":201},{"facility":205,"status":52,"city":206,"state":207,"zip":208,"country":56,"countryCode":57,"cosmosGeoPoint":209,"geoPoint":213,"contacts":34},"Juno Research LLC - Medical Center","Houston","Texas","77054",{"type":59,"coordinates":210},[211,212],-95.36327,29.76328,{"lat":212,"lon":211},{"facility":215,"status":52,"city":216,"state":207,"zip":217,"country":56,"countryCode":57,"cosmosGeoPoint":218,"geoPoint":222,"contacts":34},"Clinical Trials of Texas dba Flourish Research","San Antonio","78229",{"type":59,"coordinates":219},[220,221],-98.49363,29.42412,{"lat":221,"lon":220},{"facility":224,"status":52,"city":225,"state":226,"zip":227,"country":56,"countryCode":57,"cosmosGeoPoint":228,"geoPoint":232,"contacts":34},"Burke Internal Medicine","Burke","Virginia","22015-2234",{"type":59,"coordinates":229},[230,231],-77.27165,38.79345,{"lat":231,"lon":230},{"facility":234,"status":52,"city":235,"state":226,"zip":236,"country":56,"countryCode":57,"cosmosGeoPoint":237,"geoPoint":241,"contacts":34},"Burke International Medicine DBA Manassas Clinical Research Center","Manassas","20110",{"type":59,"coordinates":238},[239,240],-77.47527,38.75095,{"lat":240,"lon":239},{"type":243,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100609824",false,"NCT07219602","A Study to Evaluate the Effect of Obicetrapib\u002FEzetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and\u002For Metabolic Syndrome","A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and\u002For Metabolic Syndrome (RUBENS Trial)","RUBENS","Inclusion Criteria:\n\n* fasting serum LDL-C ≥ 70 mg\u002FdL (≥1.81 mmol\u002FL)\n* Have fasting TG ≥150 mg\u002FdL (≥1.7 mmol\u002FL) and \\\u003C400 mg\u002FdL (\\\u003C4.5 mmol\u002FL)\n* Know diagnosis of T2DM OR have metabolic syndrome defined as fasting TG ≥150 mg\u002FdL (≥1.7mmol\u002FL) and \\\u003C400 mg\u002FdL (\\\u003C4.5 mmol\u002FL) and at least 2 risk factors\n* Are on stable guideline-recommended lipid-lowering therapy\n* Estimated glomerular filtration rate ≥15 mL\u002Fmin\u002F1.73 m2\n\nExclusion Criteria:\n\n* Have current or any previous history of New York Heart Association class III or IV heart failure or left ventricular ejection fraction \\\u003C30%\n* Have been hospitalized for heart failure within 5 years prior to Screening\n* Have uncontrolled severe hypertension\n* Have a formal diagnosis of homozygous familial hypercholesterolemia\n* HbA1c ≥10.0% (≥0.100 hemoglobin fraction) or a fasting glucose ≥270 mg\u002FdL (≥15.0 mmol\u002FL) at Screening\n* active liver disease","ALL","18 Years",{"count":254,"type":255},300,"ESTIMATED","INTERVENTIONAL",[258],"PHASE3","This study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both as a fixed-dose combination (FDC) with ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering therapy in patients with metabolic syndrome and\u002For Type 2 Diabetes Mellitus.",[261,262,263],"Lipidemia","Type 2 Diabetes (T2DM)","Metabolic Syndrome (MetS)","2026-03-06",{"date":266,"type":267},"2026-03-10","ACTUAL",{"date":269,"type":267},"2025-12-11",{"date":271,"type":255},"2028-06",{"name":5,"class":6},20]